作者: Hugo F. Miranda , Fernando Sierralta , Nicolas Aranda , Paula Poblete , Rodrigo L. Castillo
DOI: 10.1016/J.PHAREP.2017.11.012
关键词:
摘要: Abstract Background Neuropathic pain, and subsequent hypernociception, can be induced in mice by paclitaxel (PTX) administration partial sciatic nerve ligation (PSNL). Its pharmacotherapy has been a clinical challenge, due to lack of effective treatment. In two models mouse neuropathic pain (PTX PSNL) the antinociception rosuvastatin participation proinflammatory biomarkers, interleukin (IL)- 1β, TBARS glutathione were evaluated. Methods A dose–response curve for ip was obtained on cold plate, hot plate Von Frey assays. Changes spinal cord levels IL-1β, lipid peroxidation measured at 7 14 days PTX PSNL murine models. Results or able induce peripheral neuropathy with either 14 days. Rosuvastatin dose dependent The increased IL-1β pretreatment reduced rosuvastatin. reduction glutathione, PSNL, expressed as ratio GSH/GSSG, significantly animals pretreated anti-inflammatory properties statins could underlie their beneficial effects biomarkers activation glia. Conclusion findings this study suggest potential usefulness treatment pain.